Imaging gastrointestinal stromal tumors

Cancer Control

Volumn 12, Issue 2, 2005, Pages 111-115

  Hersh, Marla R ^a   Choi, Junsung ^a   Garrett, Chris ^a   Clark, Robert ^a,b  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b Seven Rivers Community Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; BENIGN TUMOR; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL STROMAL TUMOR; HUMAN; IMMUNOPHENOTYPING; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MESENCHYMOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PERITONEUM METASTASIS; POSITRON EMISSION TOMOGRAPHY; REVIEW; ULCER;

EID: 18444398959     PISSN: 10732748     EISSN: None     Source Type: Journal    
DOI: 10.1177/107327480501200206     Document Type: Review

References (26)

1. Licht JD, Weissmann LB, Antman K. Gastrointestinal sarcomas. Semin Oncol. 1988;15:181-188.
2. Lewis JJ, Brennen MF. Soft tissue sarcomas. Curr Probl Surg. 1996;33:817-872.
3. Dematteo RP, Lewis JJ, Leung D, et al. Two hundred gastrointestinal tumors: recurrence patterns and prognostic factors for survival. Ann Surg. 2000;231:51-58.
4. Clark RA, Alexander ES. Computed tomography of gastrointestinal leiomyosarcoma. Gastrointest Radiol. 1982;7:127-129.
5. Pannu HK, Hruban RH, Fishman EK. CT of gastric leiomyosarcoma: patterns of involvement. AJR Am J Roentgenol. 1999;173:369-373.
6. Miettinen M, Lasota J. Gastrointestinal stromal tumors: definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch. 2001;438:1-12.
7. Kindblom LG, Remotti HE, Aldenborg F, et al. Gastrointestinal pacemaker cell tumour (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol. 1998;152:1259-1269
8. Fletcher CD, Berman JJ, Corless C, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol. 2002;33:459-465.
9. Miettinen M, Monihan JM, Sarlomo-Rikala M, et al. Gastrointestinal stromal tumors/smooth muscle tumors (GISTs) primary to the omentum and mesentery: clinicopathologic and immunohistochemical study of 26 cases. Am J Surg Pathol. 1999;23:1109-1118.
10. Miettinen M, El-Rifai W, Sobin LH, et al. Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a review. Hum Pathol. 2002;33:478-483.
11. Horton KM, Juluru K, Montogomery E, et al. Computed tomography imaging of gastrointestinal stromal tumors with pathology correlation. J Comput Assist Tomogr. 2004;28:811-817.
12. Hasegawa S, Semelka RC, Noone TC, et al. Gastric stromal sarcomas: correlation of MR imaging and histopathologic findings in nine patients. Radiology. 1998;208:591-595.
13. Burkill GJ, Badran M, Al-Muderis O, et al. Malignant gastrointestinal stromal tumor: distribution, imaging features, and pattern of metastatic spread. Radiology. 2003;226:527-532.
14. Ghanem N, Altehoefer C, Furtwangler A, et al. Computed tomography in gastrointestinal stromal tumors. Eur Radiol. 2003;13:1669-1678.
15. Levy AD, Remotti HE, Thompson WM, et al. Gastrointestinal stromal tumors: radiologic features with pathologic correlation. Radiographics. 2003; 23:283-304.
16. Kim HC, Lee JM, Kim SH, et al. Primary gastrointestinal stomal tumors in the omentum and mesentery: CT findings and pathologic correlations. AJR Am J Roentgenol. 2004;182:1463-1467.
17. Ludwig DJ, Traverso LW. Gut stromal tumors and their clinical behavior. Am J Surg. 1997;173:390-394.
18. Emory TS, Sobin LH, Lukes L, et al. Prognosis of gastrointestinal smoothmuscle (stromal) tumors: dependence on anatomical site. Am J Surg Pathol. 1999;23:82-87.
19. Crosby JA, Catton CN, Davis A, et al. Malignant gastrointestinal stromal tumors of the small intestine: a review of 50 cases from a prospective database. Ann Surg Oncol. 2001;8:50-59.
20. Pidhorecky I, Cheney RT, Kraybill WG, et al. Gastrointestinal stromal tumors: current diagnosis, biologic behavior, and management. Ann Surg Oncol. 2000;7:705-712.
21. Edmonson J, Marks R, Buckner J, et al. Contrast of response to D-MAP + sargramostim between patients with advanced malignant gastrointestinal stromal tumors and patients with other advanced leiomyosarcomas. Proc Annu Meet Am Soc Clin Oncol. 1999;18:541A. Abstract.
22. Plaat BE, Hollema H, Molenaar WM, et al. Soft tissue leiomyosarcomas and malignant gastrointestinal stromal tumors: differences in clinical outcome and expression of multidrug resistance proteins. J Clin Oncol. 2000;18:3211-3220.
23. Van Oosterom AT, Judson I, Verweij J, et al. Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study. Lancet. 2001;358:1421-1423.
24. Van den Abbeele AD, Badawi RD. Use of positron emission tomography in oncology and its potential role to assess response to imatinib mesylate therapy in gastrointestinal stromal tumors (GISTs). Eur J Cancer. 2002;38(suppl 5): S60-S65.
25. Jager PL, Gieterma JA, van der Graaf WT. Imatinib mesylate for the treatment of gastrointestinal stromal tumours: best monitored with FDG PET. Nucl Med Commun. 2004;25:433-438.
26. Goerres GW, Stupp R, Barghouth G. The value of PET, CT and in-line PET/CT in patients with gastrointestinal stromal tumours: long term outcome of treatment with imatinib mesylate. Eur J Nucl Med Mol Imaging. 2005;32:153-162.